“The 390-patient data will be analyzed in approx
Post# of 148154
I hope Amarex and CYDY take their time analyzing the data and develop a PR that reflects a billion dollar biotech. We don’t need another M2M PR that flopped on arrival because the information was rushed and terribly explained. If that requires an extra week, so be it.